Targeting Tumor‐Associated Antigens in Hepatocellular Carcinoma for Immunotherapy: Past Pitfalls and Future Strategies-Reference-Cited by-同舟云学术

Targeting Tumor‐Associated Antigens in Hepatocellular Carcinoma for Immunotherapy: Past Pitfalls and Future Strategies

Published:2021-02 Issue:2 Volume:73 Page:821-832
ISSN:0270-9139
Container-title:Hepatology
language:en
Short-container-title:Hepatology

Author:

Lu Ligong¹,Jiang Jun²,Zhan Meixiao¹,Zhang Hui³,Wang Qian‐Ting²,Sun Sheng‐Nan²,Guo Xiao‐Kai²,Yin Hua¹,Wei Yadong⁴,Li Shi‐You²,Liu Jun O.⁴,Li Yong¹,He You‐Wen⁵

Affiliation:

1. Zhuhai Interventional Medical Center Zhuhai Precision Medical Center Zhuhai People's HospitalZhuhai Hospital Affiliated with Jinan University Zhuhai Guangdong Province P.R. China

2. Tricision Biotherapeutic Inc. Jinwan District Zhuhai China

3. First Affiliated Hospital China Medical University Shenyang China

4. Department of Pharmacology and Molecular Sciences Johns Hopkins University School of Medicine Baltimore MD

5. Department of Immunology Duke University Medical University Medical Center Durham NC

Funder

National Natural Science Foundation of China

Natural Science Foundation of Guangdong Province

Publisher

Wiley

Subject

Hepatology

Link